Projects

To strengthen healthcare systems worldwide and better prepare them for disease outbreaks, the GHPP globally supports projects that contribute to this goal.

Status
Regions
Countries
Institutes
7 Posts
Sort by
  • Title

    Subline here
    Info here
    Button Here
  • Title

    Subline here
    Info here
    Button Here
  • Title

    Subline here
    Info here
    Button Here
  • LabTrain

    Strengthening Capacity and Infrastructure Building in Drug Quality Assurance in African countries: A Contribution by BfArM to WHO Standards and good Laboratory Practice

    Status
    ongoing
    Duration
    2023 - 2025
    Project Countries
    Ghana, Liberia, Sierra Leone, The Gambia
    Implementing Institution
    Federal Institute for Drugs and Medical Devices
    Budget
    ~ 1,300,000 EUR
    More information
  • PharmTrain2

    Building Regulatory Capacities and Infrastructure: Marketing Authorisation of Medicinal Products

    Status
    ongoing
    Duration
    2023 - 2025
    Project Countries
    Ghana, Liberia, Sierra Leone, South Africa, Südafrika, Tanzania, The Gambia, Zimbabwe
    Implementing Institution
    Federal Institute for Drugs and Medical Devices
    Budget
    ~ 1,800,000 EUR
    More information
  • LEARN

    Cross-Project Enquiry into e-LEARNing Concepts Towards Supporting Sustainable Capacity Building in the Context of GHPP

    Status
    completed
    Duration
    2020 - 2022
    Project Countries
    -
    Implementing Institution
    Federal Institute for Drugs and Medical Devices
    Budget
    ~ 57,000 EUR
    More information
  • RegTrain – PharmTrain

    Regulatory Training and Advice in the Field of Pharmaceuticals

    Status
    completed
    Duration
    2019 - 2022
    Project Countries
    Ghana, Liberia, Sierra Leone, Tanzania, The Gambia, Zimbabwe
    Implementing Institution
    Federal Institute for Drugs and Medical Devices
    Budget
    ~ 1,600,000 EUR
    More information
  • DQA and DQA PLUS

    Training African National Drug Quality Control Laboratories (NDQCLs) in Quality Assurance and Quality Management in the Context of Combating Antimicrobial Resistance

    Status
    completed
    Duration
    2016 - 2022
    Project Countries
    Cameroon, Ethiopia, Ghana, Senegal, Zimbabwe
    Implementing Institution
    Federal Institute for Drugs and Medical Devices
    Budget
    ~ 3,200,000 EUR
    More information
  • PharmTrain – Corona Global

    Drug Regulation in Health Crises: Development of a Framework for the Regional Implementation of a Risk-based Procedure for the Evaluation of Unapproved Drugs (WHO-EUL) for Southern Africa

    Status
    completed
    Duration
    2021 - 2023
    Project Countries
    Angola, Botswana, Comoros, Lesotho, Madagascar, Mozambique, Namibia, South Africa, Tanzania, Zambia, Zimbabwe
    Implementing Institution
    Federal Institute for Drugs and Medical Devices
    Budget
    ~ 230,000 EUR
    More information
  • CPA und CPA PLUS

    Combating Resistance in the Treatment of Infectious Diseases by Promoting Judicious/Rational Use of Anti-infective Drugs

    Status
    completed
    Duration
    2016 - 2022
    Project Countries
    Malawi, Zambia, Zimbabwe
    Implementing Institution
    Federal Institute for Drugs and Medical Devices
    Budget
    ~ 1,100,000 EUR
    More information